No Data
No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
Lake Street Maintains OptiNose(OPTN.US) With Buy Rating, Announces Target Price $17
Optinose Price Target Adjusted for Stock Split at Lake Street
Optinose OPTN +20% Preliminary Product Revenue; Phio Pharmaceuticals PHIO -26% Offering
Lake Street Maintains OptiNose(OPTN.US) With Buy Rating
Lake Street Remains a Buy on Optinose (OPTN)
kingrotch : thank you for your work![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...